13F-HR filed by First Light Asset Management, LLC
First Light Asset Management, LLC filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 31 holding rows worth $1,645,275,411.
- Accession
- 0001999371-26-018014
- Filer
- CIK 1600004
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 31 entries on the cover page, a total value of $1,645,275,411 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,645,275,411 with VALUE read as dollars as filed, 13F file number 028-16064. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NEOGENOMICS INC | 64049M209 | COM NEW | 12,279,523 | $179,158,241 | dollars as filed | |
| SI BONE INC | 825704109 | COM | 8,127,985 | $132,648,715 | dollars as filed | |
| AXOGEN INC | 05463X106 | COM | 2,748,361 | $126,946,795 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 930,289 | $123,477,259 | dollars as filed | |
| PALVELLA THERAPEUTICS INC | 697947109 | COMMON STOCK | 771,901 | $117,961,911 | dollars as filed | |
| TWIST BIOSCIENCE CORP | 90184D100 | COM | 727,933 | $74,889,747 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 1,360,750 | $69,058,063 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 441,586 | $66,251,148 | dollars as filed | |
| 908 DEVICES INC COM | 65443P102 | Stock | 6,282,804 | $54,660,395 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 3,023,256 | $54,297,678 | dollars as filed | |
| GENEDX HOLDINGS CORP | 81663L200 | COM CL A | 783,923 | $53,816,314 | dollars as filed | |
| SIMULATIONS PLUS INC | 829214105 | COM | 2,792,677 | $51,133,916 | dollars as filed | |
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 3,383,553 | $51,057,815 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 1,360,866 | $50,923,606 | dollars as filed | |
| NEUROPACE INC | 641288105 | COMMON STOCK | 2,861,167 | $45,463,944 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 1,095,171 | $44,496,798 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 582,004 | $39,285,270 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 2,097,215 | $39,113,060 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 963,260 | $32,259,577 | dollars as filed | |
| TRISALUS LIFE SCIENCES INC | 89680M101 | COM | 6,552,491 | $29,813,834 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 800,726 | $27,524,958 | dollars as filed | |
| HEALTH CATALYST INC | 42225T107 | COM | 12,810,861 | $25,493,613 | dollars as filed | |
| BUTTERFLY NETWORK INC | 124155102 | COM CL A | 2,642,404 | $22,249,042 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 246,577 | $21,158,772 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 345,157 | $20,063,976 | dollars as filed | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 167,092 | $19,875,593 | dollars as filed | |
| OMNICELL COM COM | 68213N109 | Stock | 452,324 | $18,780,492 | dollars as filed | |
| ATRICURE INC | 04963C209 | COM | 567,838 | $15,888,107 | dollars as filed | |
| KORU MEDICAL SYSTEMS INC | 759910102 | COMMON STOCK | 3,387,902 | $14,229,188 | dollars as filed | |
| TACTILE SYSTEMS TECHNOLOGY I | 87357P100 | COMMON STOCK | 462,562 | $13,775,096 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 85,765 | $9,522,488 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001999371-26-018014 | this filing | 2026-08-14 | acceptance time not in the bulk data set |